- call +1-201-465-4211
- email sales@marketsandresearch.biz
- Call +1-201-465-4211
- Email: sales@marketsandresearch.biz
The Prostate Cancer Screening market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest study, due to COVID-19 pandemic, the global Prostate Cancer Screening market size is estimated to be worth US$ 13820 million in 2021 and is forecast to a readjusted size of USD 22650 million by 2028 with a CAGR of 7.3% during review period. Hospitals accounting for % of the Prostate Cancer Screening global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Physical Exam segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Prostate Cancer Screening include Abbott Laboratories, Almac, Bayer, Beckman Coulter, and BioméRieux, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Prostate Cancer Screening market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Physical Exam
Laboratory Tests
Imaging Tests
Gleason Score
TNM Score
Genetic Tests
Digital Rectal Exam
Biopsy
Market segment by Application, can be divided into
Hospitals
Clinics
Research Labs
Cancer Institutes
Diagnostic Centers
Others
Market segment by players, this report covers
Abbott Laboratories
Almac
Bayer
Beckman Coulter
BioméRieux
Genomic Health
Mayo Clinic
Mdxhealth
Roche Diagnostics
Rosetta Genomics
Thermo Fisher Scientific
Hologic
Myriad Genetics
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Prostate Cancer Screening product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Prostate Cancer Screening, with revenue, gross margin and global market share of Prostate Cancer Screening from 2019 to 2022.
Chapter 3, the Prostate Cancer Screening competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Prostate Cancer Screening market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Prostate Cancer Screening research findings and conclusion, appendix and data source.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
1 Market Overview
1 Market Overview
1.1 Product Overview and Scope of Prostate Cancer Screening
1.2 Classification of Prostate Cancer Screening by Type
1.2.1 Overview: Global Prostate Cancer Screening Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Prostate Cancer Screening Revenue Market Share by Type in 2021
1.2.3 Physical Exam
1.2.4 Laboratory Tests
1.2.5 Imaging Tests
1.2.6 Gleason Score
1.2.7 TNM Score
1.2.8 Genetic Tests
1.2.9 Digital Rectal Exam
1.2.10 Biopsy
1.3 Global Prostate Cancer Screening Market by Application
1.3.1 Overview: Global Prostate Cancer Screening Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Research Labs
1.3.5 Cancer Institutes
1.3.6 Diagnostic Centers
1.3.7 Others
1.4 Global Prostate Cancer Screening Market Size & Forecast
1.5 Global Prostate Cancer Screening Market Size and Forecast by Region
1.5.1 Global Prostate Cancer Screening Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Prostate Cancer Screening Market Size by Region, (2017-2022)
1.5.3 North America Prostate Cancer Screening Market Size and Prospect (2017-2028)
1.5.4 Europe Prostate Cancer Screening Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Prostate Cancer Screening Market Size and Prospect (2017-2028)
1.5.6 South America Prostate Cancer Screening Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Prostate Cancer Screening Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Prostate Cancer Screening Market Drivers
1.6.2 Prostate Cancer Screening Market Restraints
1.6.3 Prostate Cancer Screening Trends Analysis
2 Company Profiles
2 Company Profiles
2.1 Abbott Laboratories
2.1.1 Abbott Laboratories Details
2.1.2 Abbott Laboratories Major Business
2.1.3 Abbott Laboratories Prostate Cancer Screening Product and Solutions
2.1.4 Abbott Laboratories Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Abbott Laboratories Recent Developments and Future Plans
2.2 Almac
2.2.1 Almac Details
2.2.2 Almac Major Business
2.2.3 Almac Prostate Cancer Screening Product and Solutions
2.2.4 Almac Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Almac Recent Developments and Future Plans
2.3 Bayer
2.3.1 Bayer Details
2.3.2 Bayer Major Business
2.3.3 Bayer Prostate Cancer Screening Product and Solutions
2.3.4 Bayer Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Bayer Recent Developments and Future Plans
2.4 Beckman Coulter
2.4.1 Beckman Coulter Details
2.4.2 Beckman Coulter Major Business
2.4.3 Beckman Coulter Prostate Cancer Screening Product and Solutions
2.4.4 Beckman Coulter Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 Beckman Coulter Recent Developments and Future Plans
2.5 BioméRieux
2.5.1 BioméRieux Details
2.5.2 BioméRieux Major Business
2.5.3 BioméRieux Prostate Cancer Screening Product and Solutions
2.5.4 BioméRieux Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 BioméRieux Recent Developments and Future Plans
2.6 Genomic Health
2.6.1 Genomic Health Details
2.6.2 Genomic Health Major Business
2.6.3 Genomic Health Prostate Cancer Screening Product and Solutions
2.6.4 Genomic Health Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Genomic Health Recent Developments and Future Plans
2.7 Mayo Clinic
2.7.1 Mayo Clinic Details
2.7.2 Mayo Clinic Major Business
2.7.3 Mayo Clinic Prostate Cancer Screening Product and Solutions
2.7.4 Mayo Clinic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Mayo Clinic Recent Developments and Future Plans
2.8 Mdxhealth
2.8.1 Mdxhealth Details
2.8.2 Mdxhealth Major Business
2.8.3 Mdxhealth Prostate Cancer Screening Product and Solutions
2.8.4 Mdxhealth Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Mdxhealth Recent Developments and Future Plans
2.9 Roche Diagnostics
2.9.1 Roche Diagnostics Details
2.9.2 Roche Diagnostics Major Business
2.9.3 Roche Diagnostics Prostate Cancer Screening Product and Solutions
2.9.4 Roche Diagnostics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 Roche Diagnostics Recent Developments and Future Plans
2.10 Rosetta Genomics
2.10.1 Rosetta Genomics Details
2.10.2 Rosetta Genomics Major Business
2.10.3 Rosetta Genomics Prostate Cancer Screening Product and Solutions
2.10.4 Rosetta Genomics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Rosetta Genomics Recent Developments and Future Plans
2.11 Thermo Fisher Scientific
2.11.1 Thermo Fisher Scientific Details
2.11.2 Thermo Fisher Scientific Major Business
2.11.3 Thermo Fisher Scientific Prostate Cancer Screening Product and Solutions
2.11.4 Thermo Fisher Scientific Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.12 Hologic
2.12.1 Hologic Details
2.12.2 Hologic Major Business
2.12.3 Hologic Prostate Cancer Screening Product and Solutions
2.12.4 Hologic Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Hologic Recent Developments and Future Plans
2.13 Myriad Genetics
2.13.1 Myriad Genetics Details
2.13.2 Myriad Genetics Major Business
2.13.3 Myriad Genetics Prostate Cancer Screening Product and Solutions
2.13.4 Myriad Genetics Prostate Cancer Screening Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Myriad Genetics Recent Developments and Future Plans
3 Market Competition, by Players
3 Market Competition, by Players
3.1 Global Prostate Cancer Screening Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Prostate Cancer Screening Players Market Share in 2021
3.2.2 Top 10 Prostate Cancer Screening Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Prostate Cancer Screening Players Head Office, Products and Services Provided
3.4 Prostate Cancer Screening Mergers & Acquisitions
3.5 Prostate Cancer Screening New Entrants and Expansion Plans
4 Market Size Segment by Type
4 Market Size Segment by Type
4.1 Global Prostate Cancer Screening Revenue and Market Share by Type (2017-2022)
4.2 Global Prostate Cancer Screening Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5 Market Size Segment by Application
5.1 Global Prostate Cancer Screening Revenue Market Share by Application (2017-2022)
5.2 Global Prostate Cancer Screening Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6 North America by Country, by Type, and by Application
6.1 North America Prostate Cancer Screening Revenue by Type (2017-2028)
6.2 North America Prostate Cancer Screening Revenue by Application (2017-2028)
6.3 North America Prostate Cancer Screening Market Size by Country
6.3.1 North America Prostate Cancer Screening Revenue by Country (2017-2028)
6.3.2 United States Prostate Cancer Screening Market Size and Forecast (2017-2028)
6.3.3 Canada Prostate Cancer Screening Market Size and Forecast (2017-2028)
6.3.4 Mexico Prostate Cancer Screening Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7 Europe by Country, by Type, and by Application
7.1 Europe Prostate Cancer Screening Revenue by Type (2017-2028)
7.2 Europe Prostate Cancer Screening Revenue by Application (2017-2028)
7.3 Europe Prostate Cancer Screening Market Size by Country
7.3.1 Europe Prostate Cancer Screening Revenue by Country (2017-2028)
7.3.2 Germany Prostate Cancer Screening Market Size and Forecast (2017-2028)
7.3.3 France Prostate Cancer Screening Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Prostate Cancer Screening Market Size and Forecast (2017-2028)
7.3.5 Russia Prostate Cancer Screening Market Size and Forecast (2017-2028)
7.3.6 Italy Prostate Cancer Screening Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Prostate Cancer Screening Revenue by Type (2017-2028)
8.2 Asia-Pacific Prostate Cancer Screening Revenue by Application (2017-2028)
8.3 Asia-Pacific Prostate Cancer Screening Market Size by Region
8.3.1 Asia-Pacific Prostate Cancer Screening Revenue by Region (2017-2028)
8.3.2 China Prostate Cancer Screening Market Size and Forecast (2017-2028)
8.3.3 Japan Prostate Cancer Screening Market Size and Forecast (2017-2028)
8.3.4 South Korea Prostate Cancer Screening Market Size and Forecast (2017-2028)
8.3.5 India Prostate Cancer Screening Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Prostate Cancer Screening Market Size and Forecast (2017-2028)
8.3.7 Australia Prostate Cancer Screening Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9 South America by Country, by Type, and by Application
9.1 South America Prostate Cancer Screening Revenue by Type (2017-2028)
9.2 South America Prostate Cancer Screening Revenue by Application (2017-2028)
9.3 South America Prostate Cancer Screening Market Size by Country
9.3.1 South America Prostate Cancer Screening Revenue by Country (2017-2028)
9.3.2 Brazil Prostate Cancer Screening Market Size and Forecast (2017-2028)
9.3.3 Argentina Prostate Cancer Screening Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Prostate Cancer Screening Revenue by Type (2017-2028)
10.2 Middle East & Africa Prostate Cancer Screening Revenue by Application (2017-2028)
10.3 Middle East & Africa Prostate Cancer Screening Market Size by Country
10.3.1 Middle East & Africa Prostate Cancer Screening Revenue by Country (2017-2028)
10.3.2 Turkey Prostate Cancer Screening Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Prostate Cancer Screening Market Size and Forecast (2017-2028)
10.3.4 UAE Prostate Cancer Screening Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
11 Research Findings and Conclusion
12 Appendix
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of Tables
Table 1. Global Prostate Cancer Screening Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Prostate Cancer Screening Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Prostate Cancer Screening Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Prostate Cancer Screening Revenue (USD Million) by Region (2017-2022)
Table 5. Global Prostate Cancer Screening Revenue Market Share by Region (2023-2028)
Table 6. Abbott Laboratories Corporate Information, Head Office, and Major Competitors
Table 7. Abbott Laboratories Major Business
Table 8. Abbott Laboratories Prostate Cancer Screening Product and Solutions
Table 9. Abbott Laboratories Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Almac Corporate Information, Head Office, and Major Competitors
Table 11. Almac Major Business
Table 12. Almac Prostate Cancer Screening Product and Solutions
Table 13. Almac Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Bayer Corporate Information, Head Office, and Major Competitors
Table 15. Bayer Major Business
Table 16. Bayer Prostate Cancer Screening Product and Solutions
Table 17. Bayer Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. Beckman Coulter Corporate Information, Head Office, and Major Competitors
Table 19. Beckman Coulter Major Business
Table 20. Beckman Coulter Prostate Cancer Screening Product and Solutions
Table 21. Beckman Coulter Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. BioméRieux Corporate Information, Head Office, and Major Competitors
Table 23. BioméRieux Major Business
Table 24. BioméRieux Prostate Cancer Screening Product and Solutions
Table 25. BioméRieux Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Genomic Health Corporate Information, Head Office, and Major Competitors
Table 27. Genomic Health Major Business
Table 28. Genomic Health Prostate Cancer Screening Product and Solutions
Table 29. Genomic Health Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Mayo Clinic Corporate Information, Head Office, and Major Competitors
Table 31. Mayo Clinic Major Business
Table 32. Mayo Clinic Prostate Cancer Screening Product and Solutions
Table 33. Mayo Clinic Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Mdxhealth Corporate Information, Head Office, and Major Competitors
Table 35. Mdxhealth Major Business
Table 36. Mdxhealth Prostate Cancer Screening Product and Solutions
Table 37. Mdxhealth Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. Roche Diagnostics Corporate Information, Head Office, and Major Competitors
Table 39. Roche Diagnostics Major Business
Table 40. Roche Diagnostics Prostate Cancer Screening Product and Solutions
Table 41. Roche Diagnostics Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Rosetta Genomics Corporate Information, Head Office, and Major Competitors
Table 43. Rosetta Genomics Major Business
Table 44. Rosetta Genomics Prostate Cancer Screening Product and Solutions
Table 45. Rosetta Genomics Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 47. Thermo Fisher Scientific Major Business
Table 48. Thermo Fisher Scientific Prostate Cancer Screening Product and Solutions
Table 49. Thermo Fisher Scientific Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Hologic Corporate Information, Head Office, and Major Competitors
Table 51. Hologic Major Business
Table 52. Hologic Prostate Cancer Screening Product and Solutions
Table 53. Hologic Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Myriad Genetics Corporate Information, Head Office, and Major Competitors
Table 55. Myriad Genetics Major Business
Table 56. Myriad Genetics Prostate Cancer Screening Product and Solutions
Table 57. Myriad Genetics Prostate Cancer Screening Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Prostate Cancer Screening Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Prostate Cancer Screening Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Prostate Cancer Screening by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Prostate Cancer Screening Players Head Office, Products and Services Provided
Table 62. Prostate Cancer Screening Mergers & Acquisitions in the Past Five Years
Table 63. Prostate Cancer Screening New Entrants and Expansion Plans
Table 64. Global Prostate Cancer Screening Revenue (USD Million) by Type (2017-2022)
Table 65. Global Prostate Cancer Screening Revenue Share by Type (2017-2022)
Table 66. Global Prostate Cancer Screening Revenue Forecast by Type (2023-2028)
Table 67. Global Prostate Cancer Screening Revenue by Application (2017-2022)
Table 68. Global Prostate Cancer Screening Revenue Forecast by Application (2023-2028)
Table 69. North America Prostate Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Prostate Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Prostate Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Prostate Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Prostate Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Prostate Cancer Screening Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Prostate Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Prostate Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Prostate Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Prostate Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Prostate Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Prostate Cancer Screening Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Prostate Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Prostate Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Prostate Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Prostate Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Prostate Cancer Screening Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Prostate Cancer Screening Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Prostate Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Prostate Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Prostate Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Prostate Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Prostate Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Prostate Cancer Screening Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Prostate Cancer Screening Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Prostate Cancer Screening Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Prostate Cancer Screening Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Prostate Cancer Screening Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Prostate Cancer Screening Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Prostate Cancer Screening Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Prostate Cancer Screening Picture
Figure 2. Global Prostate Cancer Screening Revenue Market Share by Type in 2021
Figure 3. Physical Exam
Figure 4. Laboratory Tests
Figure 5. Imaging Tests
Figure 6. Gleason Score
Figure 7. TNM Score
Figure 8. Genetic Tests
Figure 9. Digital Rectal Exam
Figure 10. Biopsy
Figure 11. Prostate Cancer Screening Revenue Market Share by Application in 2021
Figure 12. Hospitals Picture
Figure 13. Clinics Picture
Figure 14. Research Labs Picture
Figure 15. Cancer Institutes Picture
Figure 16. Diagnostic Centers Picture
Figure 17. Others Picture
Figure 18. Global Prostate Cancer Screening Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 19. Global Prostate Cancer Screening Revenue and Forecast (2017-2028) & (USD Million)
Figure 20. Global Prostate Cancer Screening Revenue Market Share by Region (2017-2028)
Figure 21. Global Prostate Cancer Screening Revenue Market Share by Region in 2021
Figure 22. North America Prostate Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 23. Europe Prostate Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 24. Asia-Pacific Prostate Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 25. South America Prostate Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 26. Middle East and Africa Prostate Cancer Screening Revenue (USD Million) and Growth Rate (2017-2028)
Figure 27. Prostate Cancer Screening Market Drivers
Figure 28. Prostate Cancer Screening Market Restraints
Figure 29. Prostate Cancer Screening Market Trends
Figure 30. Abbott Laboratories Recent Developments and Future Plans
Figure 31. Almac Recent Developments and Future Plans
Figure 32. Bayer Recent Developments and Future Plans
Figure 33. Beckman Coulter Recent Developments and Future Plans
Figure 34. BioméRieux Recent Developments and Future Plans
Figure 35. Genomic Health Recent Developments and Future Plans
Figure 36. Mayo Clinic Recent Developments and Future Plans
Figure 37. Mdxhealth Recent Developments and Future Plans
Figure 38. Roche Diagnostics Recent Developments and Future Plans
Figure 39. Rosetta Genomics Recent Developments and Future Plans
Figure 40. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 41. Hologic Recent Developments and Future Plans
Figure 42. Myriad Genetics Recent Developments and Future Plans
Figure 43. Global Prostate Cancer Screening Revenue Share by Players in 2021
Figure 44. Prostate Cancer Screening Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 45. Global Top 3 Players Prostate Cancer Screening Revenue Market Share in 2021
Figure 46. Global Top 10 Players Prostate Cancer Screening Revenue Market Share in 2021
Figure 47. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 48. Global Prostate Cancer Screening Revenue Share by Type in 2021
Figure 49. Global Prostate Cancer Screening Market Share Forecast by Type (2023-2028)
Figure 50. Global Prostate Cancer Screening Revenue Share by Application in 2021
Figure 51. Global Prostate Cancer Screening Market Share Forecast by Application (2023-2028)
Figure 52. North America Prostate Cancer Screening Sales Market Share by Type (2017-2028)
Figure 53. North America Prostate Cancer Screening Sales Market Share by Application (2017-2028)
Figure 54. North America Prostate Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 55. United States Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 56. Canada Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. Mexico Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. Europe Prostate Cancer Screening Sales Market Share by Type (2017-2028)
Figure 59. Europe Prostate Cancer Screening Sales Market Share by Application (2017-2028)
Figure 60. Europe Prostate Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 61. Germany Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 62. France Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 63. United Kingdom Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 64. Russia Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Italy Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. Asia-Pacific Prostate Cancer Screening Sales Market Share by Type (2017-2028)
Figure 67. Asia-Pacific Prostate Cancer Screening Sales Market Share by Application (2017-2028)
Figure 68. Asia-Pacific Prostate Cancer Screening Revenue Market Share by Region (2017-2028)
Figure 69. China Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. Japan Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 71. South Korea Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 72. India Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 73. Southeast Asia Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Australia Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. South America Prostate Cancer Screening Sales Market Share by Type (2017-2028)
Figure 76. South America Prostate Cancer Screening Sales Market Share by Application (2017-2028)
Figure 77. South America Prostate Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 78. Brazil Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Argentina Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. Middle East and Africa Prostate Cancer Screening Sales Market Share by Type (2017-2028)
Figure 81. Middle East and Africa Prostate Cancer Screening Sales Market Share by Application (2017-2028)
Figure 82. Middle East and Africa Prostate Cancer Screening Revenue Market Share by Country (2017-2028)
Figure 83. Turkey Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 84. Saudi Arabia Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 85. UAE Prostate Cancer Screening Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 86. Methodology
Figure 87. Research Process and Data Source
Please feel free to write an email to us or to use our electronic ticketing system.
